Skip to main content
. 2013 Jan 2;98(2):E379–E387. doi: 10.1210/jc.2012-3148

Table 2.

Clinical Characteristics of CAH Probands Aged 7–35 Years Old According to TNXB Haploinsufficiency Carriership

Variable CAH-X (n = 13) CAH Control (n = 103) P Value
Age (mean ± sd) 18.4 ± 8.9 17.0 ± 7.8 .55
Females [no. (%)] 7 (53.8) 59 (57.3) 1.00
Joints
    Generalized joint hypermobility [no. (%)]a 8 (61.5) 14 (13.6) <.001
    Hypermobility of large joints [no. (%)]b 6 (46.2) 5 (4.9) <.001
    Hypermobility of small joints [no. (%)]c 7 (53.8) 18 (17.5) .007
    More than 1 joint dislocation [no. (%)] 3 (23.1) 1 (0.97) .004
    Arthralgia 4 or more joints [no. (%)]d 4 (30.8) 3 (2.9) .003
    Arthralgia 1–3 joints or back pain [no. (%)]d 4 (30.8) 5 (4.9) .009
Skin
    Easy bruising [no. (%)] 6 (46.2) 25 (24.3) .11
    Loose skin [no. (%)] 1 (7.7) 0 .11
    Striae [no. (%)] 3 (23.1) 18 (17.5) .70
    Widened scar [no. (%)] 4 (30.8) 5 (4.9) .009
    Androgenic alopecia (females) [no. (%)] 2 (15.4) 4 (6.8) .14
a

Generalized hypermobility was defined as a Beighton score 5 of 9 or greater for children and 4 of 9 or greater for postpubertal adolescents and adults.

b

Hypermobility of large joints was defined as hypermobility of large joints not assessed in Beighton, shoulder, and hip.

c

Hypermobility of small joints defined as hypermobility of the hands or feet.

d

Arthralgia and back pain is of at least 3 months' duration.